As of January 24, 2025, Pulse Biosciences (PLSE) has a market cap of $1.15 billion USD. According to our data, Pulse Biosciences is ranked No.4991 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 24, 2025 | $1.15 B |
7.52%
|
Dec 31, 2024 | $1.07 B |
42.24%
|
Dec 29, 2023 | $0.75 B |
341.88%
|
Dec 30, 2022 | $0.17 B |
-81.30%
|
Dec 31, 2021 | $0.91 B |
-37.93%
|
Dec 31, 2020 | $1.47 B |
77.93%
|
Dec 31, 2019 | $0.82 B |
17.02%
|
Dec 31, 2018 | $0.70 B |
-51.44%
|
Dec 29, 2017 | $1.45 B |
263.08%
|
Dec 30, 2016 | $0.40 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Cutera
CUTR
|
$9.43 M |
0.000 M
|
USA
|
InMode
INMD
|
$1.30 B |
0.000 M
|
Israel
|
Apyx Medical
APYX
|
$57.22 M |
0.000 M
|
USA
|
Viveve Medical
VIVE
|
$0.00 M |
0.002 M
|
USA
|
Market Cap | = | PLSE Stock Price | * | PLSE Shares Outstanding |
= | $18.72 | * | 61.52 M | |
= | $1.15 B |